83 related articles for article (PubMed ID: 314956)
21. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
22. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
23. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
24. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
Fink PJ; Rammensee HG; Bevan MJ
J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
[TBL] [Abstract][Full Text] [Related]
25. Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young mice.
Schwartz DH; Doherty PC
J Immunol; 1981 Oct; 127(4):1411-4. PubMed ID: 6974190
[TBL] [Abstract][Full Text] [Related]
26. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
Okada M; Henney CS
J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
[No Abstract] [Full Text] [Related]
27. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
Pilarski LM; Carayanniotis G
J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
[TBL] [Abstract][Full Text] [Related]
28. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region.
Forman J
J Immunol; 1979 Dec; 123(6):2451-5. PubMed ID: 387870
[TBL] [Abstract][Full Text] [Related]
29. Ontogeny of cell-mediated cytotoxicity: induction of CTL in early postnatal thymocytes.
Widmer MB; Cooper EL
J Immunol; 1979 Jan; 122(1):291-5. PubMed ID: 310832
[TBL] [Abstract][Full Text] [Related]
30. Ontogeny of anti-self-trinitrophenyl cytotoxic T-cell responses.
Schmitt-Verhulst AM; Cooley MA; Buferne M
Thymus; 1981 Aug; 3(2):77-85. PubMed ID: 6974916
[TBL] [Abstract][Full Text] [Related]
31. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
Hurtenbach U; Shearer GM
J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
[TBL] [Abstract][Full Text] [Related]
32. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
Gorczynski RM; Macrae S
Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
[TBL] [Abstract][Full Text] [Related]
33. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
Huston DP; Tavana G; Rich RR; Gressens SE
J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
[TBL] [Abstract][Full Text] [Related]
34. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
35. Naturally occurring cytotoxic T lymphocyte precursors with specificity for an Ig idiotype.
Dohi Y; Yamada K; Ohno N; Aoki M; Takagaki Y; Nisonoff A; Shinka S
J Immunol; 1988 Dec; 141(11):3804-9. PubMed ID: 2460550
[TBL] [Abstract][Full Text] [Related]
36. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
Olsson L; Ebbesen P
J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
[No Abstract] [Full Text] [Related]
37. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
Moser G; Burakoff SJ; Abbas AK
J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
[TBL] [Abstract][Full Text] [Related]
38. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
39. Generation of autoreactive cytotoxic T lymphocytes under limiting dilution conditions.
Reimann J; Miller RG
J Immunol; 1983 Nov; 131(5):2128-34. PubMed ID: 6226733
[TBL] [Abstract][Full Text] [Related]
40. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
